Okumura Lucas Miyake, Rotta Inajara, Correr Cassyano Januário
PGY 2 Oncology and Hematology Clinical Hospital, Federal University of Paraná, Curitiba, PR, Brazil,
Int J Clin Pharm. 2014 Oct;36(5):882-91. doi: 10.1007/s11096-014-9982-1. Epub 2014 Jul 23.
Background Pharmacists' counseling has improved health-related outcomes in many acute and chronic conditions. Several studies have shown how pharmacists have been contributing to reduce morbidity and mortality related to drug-therapy (MMRDT). However, there still is a lack of reviews that assemble evidence-based clinical pharmacists' counseling. Equally, there is also a need to understand structure characteristics, processes and technical contents of these clinical services. Aim of the review To review the structure, processes and technical contents of pharmacist counseling or education reported in randomized controlled trials (RCT) that had positive health-related outcomes. Methods We performed a systematic search in specialized databases to identify RCT published between 1990 and 2013 that have evaluated pharmacists' counseling or educational interventions to patients. Methodological quality of the trials was assessed using the Jadad scale. Pharmacists' interventions with positive clinical outcomes (p < 0.05) were evaluated according to patients' characteristics, setting and timing of intervention, reported written and verbal counseling. Results 753 studies were found and 101 RCT matched inclusion criteria. Most of the included RCTs showed a Jadad score between two (37 studies) and three (32 studies). Pharmacists were more likely to provide counseling at ambulatories (60 %) and hospital discharge (25 %); on the other hand pharmacists intervention were less likely to happen when dispensing a medication. Teaching back and explanations about the drug therapy purposes and precautions related to its use were often reported in RCT, whereas few studies used reminder charts, diaries, group or electronic counseling. Most of studies reported the provision of a printed material (letter, leaflet or medication record card), regarding accessible contents and cultural-concerned informations about drug therapy and disease. Conclusion Pharmacist counseling is an intervention directed to patients' health-related needs that improve inter-professional and inter-institutional communication, by collaborating to integrate health services. In spite of reducing MMRDT, we found that pharmacists' counseling reported in RCT should be better explored and described in details, hence collaborating to improve medication-counseling practice among other countries and settings.
药剂师的咨询服务已在许多急慢性疾病中改善了与健康相关的结局。多项研究表明药剂师如何为降低与药物治疗相关的发病率和死亡率(MMRDT)做出贡献。然而,目前仍缺乏对基于证据的临床药剂师咨询服务的综述。同样,也需要了解这些临床服务的结构特征、流程和技术内容。综述目的:回顾随机对照试验(RCT)中报告的具有积极健康相关结局的药剂师咨询或教育的结构、流程和技术内容。方法:我们在专业数据库中进行了系统检索,以识别1990年至2013年间发表的评估药剂师对患者咨询或教育干预的RCT。使用Jadad量表评估试验的方法学质量。根据患者特征、干预的环境和时间、报告的书面和口头咨询,对具有积极临床结局(p<0.05)的药剂师干预进行评估。结果:共检索到753项研究,101项RCT符合纳入标准。大多数纳入的RCT的Jadad评分为2分(37项研究)至3分(32项研究)。药剂师更有可能在门诊(60%)和出院时(25%)提供咨询;另一方面,药剂师在配药时进行干预的可能性较小。RCT中经常报告对药物治疗目的及与其使用相关的注意事项进行复述和解释,而很少有研究使用提醒图表、日记、小组或电子咨询。大多数研究报告提供了一份印刷材料(信件、传单或用药记录卡),内容涉及药物治疗和疾病的可获取信息及文化相关信息。结论:药剂师咨询是针对患者健康相关需求的一种干预措施,通过协作整合卫生服务,改善跨专业和跨机构的沟通。尽管降低了MMRDT,但我们发现RCT中报告的药剂师咨询应得到更好的探索和详细描述,从而有助于改善其他国家和环境中的用药咨询实践。